Display Settings:

Format

Send to:

Choose Destination
    ORL J Otorhinolaryngol Relat Spec. 2009;71(3):148-52. Epub 2009 May 7.

    Therapy of snoring and obstructive sleep apnea using the Velumount palatal device.

    Source

    ENT Clinic, Cantonal Hospital of Liestal, CH-4410 Liestal, Switzerland. kurt.tschopp@ksli.ch

    Abstract

    OBJECTIVES:

    The aim of the present study is to investigate the efficacy of the Velumount device. Methods: In a prospective cohort study 40 patients were examined with and without Velumount. The apnea-hypopnea index and average esophageal pressure were measured using nocturnal manometry of the upper airways, combined with respiratory polygraphy. The snoring index (1-10) and daytime sleepiness using the Epworth Sleepiness Scale were assessed by means of a questionnaire.

    RESULTS:

    Using Velumount the snoring index was reduced from on average 8.4 (SD +/- 1.3) to 3.7 (SD +/- 2.5), the Epworth Sleepiness Scale score from on average 7.9 (SD +/- 4.4) to 3.8 (SD +/- 3.4) and esophageal pressure from on average 14.8 cm H(2)O (SD +/- 6.7) to 11.2 cm H(2)O (SD +/- 6.4). In patients (n = 25) with obstructive sleep apnea, the average apnea-hypopnea index was 24.3 (SD +/- 10.1) without and 13.6 (SD +/- 12.2) with Velumount. All changes were highly significant.

    CONCLUSIONS:

    The Velumount device is effective for the treatment of snoring and obstructive sleep apnea. The effect is similar to that reported from uvulopalatopharyngoplasty.

    PMID:
    19420980
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for S. Karger AG, Basel, Switzerland

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk